Novartis investigative site

Pisa 56126

0 studies enrolling now · 10 studies all time

What they study most

Alzheimer Disease, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia, Chronic Obstructive Pulmonary Disease, Islet Cell Carcinoma, Neuroendocrine Carcinoma, Neuroendocrine Tumor, Non-radiographic Spondyloarthritis, Pancreatic Neoplasms, Psoriatic Arthritis, Pulmonary Arterial Hypertension

Studies at this site

• Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis — Completed
• Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA) — Completed
• Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis — Completed
• Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients. — Completed
• Imatinib (QTI571) in Pulmonary Arterial Hypertension — Completed
• Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia — Completed
• Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy — Completed
• Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline — Completed
• Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia — NO_LONGER_AVAILABLE
• A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD) — Completed